SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006203
Filing Date
2024-04-30
Accepted
2024-04-30 08:00:35
Documents
92
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20240331x10q.htm   iXBRL 10-Q 1343712
2 EX-10.1 hrmy-20240331xex10d1.htm EX-10.1 18770
3 EX-10.2 hrmy-20240331xex10d2.htm EX-10.2 19395
4 EX-31.1 hrmy-20240331xex31d1.htm EX-31.1 16276
5 EX-31.2 hrmy-20240331xex31d2.htm EX-31.2 16877
6 EX-32.1 hrmy-20240331xex32d1.htm EX-32.1 9977
7 EX-32.2 hrmy-20240331xex32d2.htm EX-32.2 9502
  Complete submission text file 0001558370-24-006203.txt   7483592

Data Files

Seq Description Document Type Size
8 EX-101.SCH hrmy-20240331.xsd EX-101.SCH 64169
9 EX-101.CAL hrmy-20240331_cal.xml EX-101.CAL 73330
10 EX-101.DEF hrmy-20240331_def.xml EX-101.DEF 179262
11 EX-101.LAB hrmy-20240331_lab.xml EX-101.LAB 529790
12 EX-101.PRE hrmy-20240331_pre.xml EX-101.PRE 373266
96 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240331x10q_htm.xml XML 1271830
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 24894089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)